January 12, 2026: The GLP-1 MDL, which includes Wegovy lawsuits, now has over 3,000 cases pending in federal court
Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics
Although todays semaglutide market is largely OOP, falling costs could tip the scales for wider public reimbursement where insurers may be more willing to cover AOMs, in addition to simplifying coverage by removing restrictions such as prior authorisation (see section above on public reimbursement)
Exposure to ethinylestradiol and levonorgestrel was similar when administered alone or with oral semaglutide, indicating that their bioavailability is not affected by co-administration with oral semaglutide [44]
Some individuals may prefer the convenience of a weekly injection, while others may find it easier to incorporate a daily routine Approved indications: Saxenda is specifically FDA-approved for weight management, while Ozempic is primarily approved for managing type 2 diabetes